Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Wall Street
Price Targets
AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AUPH
is 17.05 USD
with a low forecast of 13.13 USD and a high forecast of 22.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AUPH's stock price target?
Price Target
17.05
USD
According to Wall Street analysts, the average 1-year price target for
AUPH
is 17.05 USD
with a low forecast of 13.13 USD and a high forecast of 22.05 USD.
What is Aurinia Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
Aurinia Pharmaceuticals Inc's revenue is
50%.
The projected
CAGR
for the next 3 years is
17%.
What is Aurinia Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
22%
The
compound annual growth rate
of Aurinia Pharmaceuticals Inc's operating income for the next 3 years is
22%.
What is Aurinia Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-16%
The
compound annual growth rate
of Aurinia Pharmaceuticals Inc's net income for the next 3 years is
-16%.
